[Pharma Boardroom] Jisoo Pae – CEO, Genome & Company

Genome & Company, with a market cap of USD 280 million, is the highest valued microbiome company worldwide. Dr Jisoo Pae, its co-founder and CEO, sat down with PharmaBoardroom to shed light on the company’s origins, its collaboration with Big Pharma, and the ease of gaining capital investment for a Korean biotech.


No comments

    댓글은 닫혔습니다.